# Mersana Therapeutics

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/mersana-therapeutics/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | company in Cambridge, United States |
| OpenAlex ID | https://openalex.org/F4320316932 |
| ROR ID | https://ror.org/05jyg6z06 |
| Works | 469 |

## Funder papers

- [Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial](https://scholariq.org/papers/niraparib-first-line-maintenance-therapy-in-patients-with-newly-diagnosed/)
- [Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial](https://scholariq.org/papers/efficacy-and-safety-of-niraparib-in-patients-aged-65-years-and-older-with/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.